Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Haematologica
|
May 30, 2024
Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinib
Zachary Risch, Benjamin H Kaffenberger, Catherine G Chung, et al.
The Journal of Molecular Diagnostics : JMD
|
August 14, 2017
Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors
Julie W Reeser, Dorrelyn Martin, Jharna Miya, et al.
Cell Reports
|
December 8, 2016
Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation in Prostate Cancer
Ram S Mani, Mohammad A Amin, Xiangyi Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2025
Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical Trial
Chunjie Li, Anne M Noonan, John Hays, et al.
International Journal of Molecular Sciences
|
August 29, 2024
Mature MUC5AC Expression in Resected Pancreatic Ductal Adenocarcinoma Predicts Treatment Response and Outcomes
Ashish Manne, Ashwini Esnakula, Ankur Sheel, et al.
Nature Genetics
|
January 15, 2013
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
Dan R Robinson, Yi-Mi Wu, Shanker Kalyana-Sundaram, et al.
Oncotarget
|
November 5, 2017
Analytic validation and real-time clinical application of an amplicon-based targeted gene panel for advanced cancer
Michele R Wing, Julie W Reeser, Amy M Smith, et al.
The Lancet. Gastroenterology & Hepatology
|
August 6, 2021
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study
Milind Javle, Sameek Roychowdhury, Robin Kate Kelley, et al.
JCO Precision Oncology
|
January 9, 2023
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations
Emily L Hoskins, Eric Samorodnitsky, Michele R Wing, et al.
NPJ Precision Oncology
|
July 3, 2025
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers
Emily L Hoskins, Raven Vella, Julie W Reeser, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Haematologica
|
May 30, 2024
Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinib
Zachary Risch, Benjamin H Kaffenberger, Catherine G Chung, et al.
The Journal of Molecular Diagnostics : JMD
|
August 14, 2017
Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors
Julie W Reeser, Dorrelyn Martin, Jharna Miya, et al.
Cell Reports
|
December 8, 2016
Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation in Prostate Cancer
Ram S Mani, Mohammad A Amin, Xiangyi Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2025
Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical Trial
Chunjie Li, Anne M Noonan, John Hays, et al.
International Journal of Molecular Sciences
|
August 29, 2024
Mature MUC5AC Expression in Resected Pancreatic Ductal Adenocarcinoma Predicts Treatment Response and Outcomes
Ashish Manne, Ashwini Esnakula, Ankur Sheel, et al.
Nature Genetics
|
January 15, 2013
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
Dan R Robinson, Yi-Mi Wu, Shanker Kalyana-Sundaram, et al.
Oncotarget
|
November 5, 2017
Analytic validation and real-time clinical application of an amplicon-based targeted gene panel for advanced cancer
Michele R Wing, Julie W Reeser, Amy M Smith, et al.
The Lancet. Gastroenterology & Hepatology
|
August 6, 2021
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study
Milind Javle, Sameek Roychowdhury, Robin Kate Kelley, et al.
JCO Precision Oncology
|
January 9, 2023
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations
Emily L Hoskins, Eric Samorodnitsky, Michele R Wing, et al.
NPJ Precision Oncology
|
July 3, 2025
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers
Emily L Hoskins, Raven Vella, Julie W Reeser, et al.
Page
of 8